CYTORI THERAPEUTICS INC. news, videos and press releases
For more news please use our advanced search feature.
CYTORI THERAPEUTICS INC. - More news...
CYTORI THERAPEUTICS INC. - More news...
- Plus Therapeutics to Participate in Upcoming January Conferences
- Plus Therapeutics Completes Sixth Dosing Cohort in ReSPECT™ Glioblastoma Trial
- Plus Therapeutics to Present at 13th Annual LD Micro Main Event Conference
- Plus Therapeutics Expands ReSPECT™ Clinical Trial to MD Anderson Cancer Center
- Plus Therapeutics Announces Positive Interim Data from ReSPECT™ Phase 1 Clinical Trial in Recurrent Glioblastoma
- Plus Therapeutics to Participate in Upcoming November Investor Conferences
- Plus Therapeutics Announces Webinar to Present ReSPECT™ Glioblastoma Clinical Trial Update
- Plus Therapeutics Announces Formation of Scientific Advisory Board
- Plus Therapeutics Announces Initiation of Final Cohort of ReSPECT™ Glioblastoma Trial
- Plus Therapeutics Reports Third Quarter 2020 Financial Results and Business Highlights
- Plus Therapeutics to Present at the Cancer Innovation Summit
- Plus Therapeutics to Announce Third Quarter 2020 Financial Results and Host Conference Call on October 22, 2020
- Plus Therapeutics Announces Brain Cancer Clinical Advisory Team
- ReSPECT Glioblastoma Clinical Trial Data to be Presented at 2020 Society for Neuro-Oncology Annual Meeting
- Plus Therapeutics Receives Fast Track Designation From FDA for Its Novel Glioblastoma Treatment
- Plus Therapeutics, Inc. to Present at the 22nd H. C. Wainwright Annual Global Investor Conference on September 15, 2020
- Plus Therapeutics, Inc. to Present at the 9th Annual Gateway Conference on September 10, 2020
- Plus Therapeutics, Inc. receives FDA Orphan Drug Designation for its Novel Glioblastoma Treatment
- Plus Therapeutics, Inc. to Present at The LD 500 Virtual Conference
- Plus Therapeutics Reports Second Quarter 2020 Financial and Business Results
- Plus Therapeutics To Report Second Quarter Fiscal Year 2020 Financial Results And Corporate Update on August 10, 2020
- Plus Therapeutics Completes Fifth Dose Escalation Cohort of the ReSPECT™ Glioblastoma Clinical Trial and Expands Trial Sites
- Plus Therapeutics to Present at the YAFO Access China Partnering Conference on July 30, 2020
- Plus Therapeutics Announces Inducement Stock Grants
- Plus Therapeutics Reports First Quarter 2020 Financial and Business Results
- Plus Therapeutics Announces Patient-Focused Presentation Supporting Brain Tumor Awareness Month
- Plus Therapeutics Announces Closing of Agreement To License Novel Oncology Platform
- Plus Therapeutics To Report First Quarter Fiscal Year 2020 Financial Results and Corporate Update on May 14, 2020
- Plus Therapeutics Donates Personal Protective Equipment to Scripps Health to Confront COVID-19 Pandemic
- Plus Therapeutics Announces Dr. Gregory Stein as Head of Clinical Development
